ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

66 hedge funds and large institutions have $77M invested in Zynerba Pharmaceuticals, Inc in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 20 closing their positions.

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
1.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
19
Reduced
15
Closed
20
Calls
$17.1M
Puts
$28.8M
Net Calls
-$11.7M
Net Calls Change
-$14.1M
Name Holding Trade Value Shares
Change
Shares
Change %
LCM
76
Laurion Capital Management
New York
-$586K -29,154 Closed
PI
77
Putnam Investments
Massachusetts
-$562K -27,970 Closed
DTL
78
Dynamic Technology Lab
Singapore
-$410K -20,407 Closed
SCM
79
Segantii Capital Management
Hong Kong
-$291K -14,500 Closed
AGM
80
Alpine Global Management
New York
-$209K -10,402 Closed
SSA
81
Schonfeld Strategic Advisors
New York
-$205K -10,162 Closed
SC
82
Sculptor Capital
New York
-$193K -9,600 Closed
SG Americas Securities
83
SG Americas Securities
New York
-$188K -9,364 Closed
FPF
84
FNY Partners Fund
New York
-$90K -4,500 Closed
AIM
85
Acrospire Investment Management
Illinois
-$11K -546 Closed
MWM
86
MinichMacGregor Wealth Management
New York
-$10K -500 Closed